コンテンツへスキップ
Merck
  • Development of a metabolomic radiation signature in urine from patients undergoing total body irradiation.

Development of a metabolomic radiation signature in urine from patients undergoing total body irradiation.

Radiation research (2014-03-29)
Evagelia C Laiakis, Tytus D Mak, Sebastien Anizan, Sally A Amundson, Christopher A Barker, Suzanne L Wolden, David J Brenner, Albert J Fornace
要旨

The emergence of the threat of radiological terrorism and other radiological incidents has led to the need for development of fast, accurate and noninvasive methods for detection of radiation exposure. The purpose of this study was to extend radiation metabolomic biomarker discovery to humans, as previous studies have focused on mice. Urine was collected from patients undergoing total body irradiation at Memorial Sloan-Kettering Cancer Center prior to hematopoietic stem cell transplantation at 4-6 h postirradiation (a single dose of 1.25 Gy) and 24 h (three fractions of 1.25 Gy each). Global metabolomic profiling was obtained through analysis with ultra performance liquid chromatography coupled to time-of-flight mass spectrometry (TOFMS). Prior to further analyses, each sample was normalized to its respective creatinine level. Statistical analysis was conducted by the nonparametric Kolmogorov-Smirnov test and the Fisher's exact test and markers were validated against pure standards. Seven markers showed distinct differences between pre- and post-exposure samples. Of those, trimethyl-l-lysine and the carnitine conjugates acetylcarnitine, decanoylcarnitine and octanoylcarnitine play an important role in the transportation of fatty acids across mitochondria for subsequent fatty acid β-oxidation. The remaining metabolites, hypoxanthine, xanthine and uric acid are the final products of the purine catabolism pathway, and high levels of excretion have been associated with increased oxidative stress and radiation induced DNA damage. Further analysis revealed sex differences in the patterns of excretion of the markers, demonstrating that generation of a sex-specific metabolomic signature will be informative and can provide a quick and reliable assessment of individuals in a radiological scenario. This is the first radiation metabolomics study in human urine laying the foundation for the use of metabolomics in biodosimetry and providing confidence in biomarker identification based on the overlap between animal models and humans.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
L-リシン, ≥98% (TLC)
Sigma-Aldrich
尿酸, ≥99%, crystalline
Sigma-Aldrich
ヒポキサンチン, ≥99.0%
Sigma-Aldrich
L-リシン 一塩酸塩, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
L-リシン, crystallized, ≥98.0% (NT)
Sigma-Aldrich
キサンチン, ≥99%
Sigma-Aldrich
ヒポキサンチン, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
4-ニトロ安息香酸, 98%
Sigma-Aldrich
尿酸, BioXtra, ≥99% (HPLC)
Sigma-Aldrich
O-アセチル-L-カルニチン 塩酸塩, ≥99% (titration), powder
Sigma-Aldrich
キサンチン, ≥99.5% (HPLC), purified by recrystallization
Sigma-Aldrich
キサンチン, BioUltra, ≥99%
Sigma-Aldrich
クレアチニン, anhydrous, ≥98%
Sigma-Aldrich
L-リシン 一塩酸塩, reagent grade, ≥98% (HPLC)
Sigma-Aldrich
デブリソキン 硫酸
Supelco
L-リシン, analytical standard
Supelco
クレアチニン, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
L-リシン 一塩酸塩, Pharmaceutical Secondary Standard; Certified Reference Material
リシン 塩酸塩, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
4-ニトロ安息香酸, purum, ≥98.0% (HPLC)
Sigma-Aldrich
L-リシン 一塩酸塩, BioUltra, ≥99.5% (AT)
Supelco
L-Lysine hydrochloride solution, 100 mM amino acid in 0.1 M HCl, analytical standard
Supelco
L-リシン 一塩酸塩, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
L-リシン 一塩酸塩, SAJ special grade, ≥99.0%
ヒポキサンチン, European Pharmacopoeia (EP) Reference Standard